{"id":"W4292433546","doi":"","title":"Dabigatran: life-threatening bleeding.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Warfarin; Idarucizumab; Rivaroxaban; Direct thrombin inhibitor; Concomitant; Antidote; Prothrombin complex concentrate; Atrial fibrillation; Anticoagulant; Pharmacovigilance; Intensive care medicine; Anesthesia; Surgery; Internal medicine; Adverse effect; Toxicity","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002732294,0.0005036824,0.0003679626,0.0008521865,0.0003359568,0.0007472838,0.0002866143,0.0008147283,0.03081164],"category_scores_gemma":[0.001669342,0.00007359225,0.0002615953,0.001165644,0.000258456,0.0005330294,0.0006556442,0.001018647,0.02258552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002739922,"about_ca_system_score_gemma":0.000851192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006916829,"about_ca_topic_score_gemma":0.0009418412,"domain_scores_codex":[0.9996033,0.00007858301,0.00009162732,0.00002485249,0.0001515804,0.00005007579],"domain_scores_gemma":[0.9994761,0.00007494872,0.0002038983,0.00003264197,0.00009979444,0.0001126263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.0004911066,0.00007332239,0.008452722,0.001879291,0.00005005414,0.005100454,0.0001366218,0.00004755339,0.0005916436,0.005130447,0.4779671,0.5000797],"study_design_scores_gemma":[0.00009620639,0.00009070989,0.01035163,0.001552386,0.00005281669,0.02092172,0.0001144693,0.00007762566,0.0004302708,0.004416949,0.9618825,0.00001279396],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.0249237,0.3914021,0.005862284,0.0463271,0.01151045,0.0007029651,0.01755365,0.001962826,0.499755],"genre_scores_gemma":[0.3106099,0.3756464,0.007105232,0.03667934,0.01461147,0.0006017106,0.02775431,0.0003960622,0.2265956],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03081164,"threshold_uncertainty_score":0.1030752,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08267691738481038,"score_gpt":0.2750391876788301,"score_spread":0.1923622702940197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}